October 2014 Vol 7, No 7
Evaluation of Dabigatran for Appropriateness of Use and Bleeding Events in a Community Hospital Setting
Anastasia L Armbruster, PharmD, BCPS, Katie S Buehler, PharmD, BCPS, Sun H Min, PharmD, Margaret Riley, PharmD, Michael W Daly, PharmD, MSCI, BCPS
The development of innovative medications is largely a private enterprise that relies chiefly on the investment of pharmaceutical companies in research and development (R&D).
Accurate Prescribing Key to Safe Use of Anticoagulants in Patients with Nonvalvular Atrial Fibrillation
Marco daCosta DiBonaventura, PhD, Ronda Copher, PhD, Enrique Basurto, MSc, Claudio Faria, PharmD, MPH, Rose Lorenzo, BA
The following summaries highlight some of the key posters presented at the Academy of Managed Care Pharmacy Nexus14 meeting on October 7-10, 2014, in Boston, MA, focusing on findings with significant implications for payers, employers, providers, policymakers, patients, and other healthcare stakeholders.
Results 1 - 5 of 5